Drug Shortage Report for IRINOTECAN HYDROCHLORIDE INJECTION USP

Last updated on 2018-02-26 History
Report ID 32661
Drug Identification Number 02258218
Brand name IRINOTECAN HYDROCHLORIDE INJECTION
Common or Proper name IRINOTECAN
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) IRINOTECAN HYDROCHLORIDE
Strength(s) 20MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 1 x 2mL
ATC code L01XX
ATC description OTHER ANTINEOPLASTIC AGENTS
Reason for shortage Demand increase for the drug.
Anticipated start date 2018-04-09
Actual start date
Estimated end date
Actual end date 2018-02-26
Shortage status Avoided shortage
Updated date 2018-02-26
Company comments
Health Canada comments
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2017-12-12 English Compare
v2 2017-12-12 French Compare
v3 2018-01-12 English Compare
v4 2018-02-26 English Compare
v5 2018-02-26 French Compare